Arthritis treatment majorly focuses on relieving symptoms and improving the joint function. Researchers at the University of Queensland (UQ) in Australia have developed a breakthrough rheumatoid arthritis treatment targeting the underlying cause of the disease rather than just focusing on the symptoms.
Lead researcher Ranjeny Thomas from UQ Diamantina Institute said, "The treatment worked by causing a patient's immune system to ignore a peptide it wrongly fought. It's rather re-educating the immune system so that instead of responding to that enemy to actually stop responding or to make a counter regulatory peace-making effort against the enemy so that things will quieten down."
Researchers have designed this treatment for people with the most common form of rheumatoid arthritis called CCP-positive.